
UK-based stem cell therapy firm ReNeuron has appointed Olav Hellebø to be its new chief executive. Since starting his pharma …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

